AN

Ankush Nandra

Director Director DIN 08737981
DIN 08737981 First appointment May 2020 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since May 2020
Shareholding value Locked Premium profile

About Ankush Nandra

Data last updated:

Ankush Nandra has 6 years in corporate governance. Formerly with 1 company, such as Astrazeneca Pharma India Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08737981
Primary Designation Director
First Appointment 18 May 2020
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Astrazeneca Pharma India Limited L24231KA1979PLC003563
Director18 May 20201979Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Astrazeneca Pharma India Limited
Premium access

Shareholding and investment profile for Ankush Nandra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ankush Nandra

Ankush Nandra has 6 years in corporate governance. Formerly with 1 company, such as Astrazeneca Pharma India Limited. Engaged in General Business. Contributes to corporate operations.

Ankush Nandra is associated with 0 companies as a director.

Ankush Nandra has expertise in General Business.

Ankush Nandra has 6 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available